STAT

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefitWorldPing

Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout…

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

Study shows university's advising model boosts international studentsWorldPing
Phys.org

Study shows university's advising model boosts international students

Ling LeBeau and Steve Schaffling spent five years building and refining a framework for supporting international students at Syracuse University, culminating in the establishment of the International Student Success Model, launched by the Office of A…

Brief by WorldPing · Original reporting by Phys.org